
[Federal Register Volume 88, Number 153 (Thursday, August 10, 2023)]
[Notices]
[Pages 54323-54324]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17149]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2022-N-2186]


Request for Nominations on the Tobacco Products Scientific 
Advisory Committee--Small Business Pool

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting that any 
small business tobacco manufacturing industry organizations interested 
in participating in the selection of a nonvoting industry 
representative to serve on the Tobacco Products Scientific Advisory 
Committee for the Center for Tobacco Products notify FDA in writing. 
FDA is also requesting nominations for nonvoting industry 
representatives to be included in a pool of individuals to represent 
the interests of the small business tobacco manufacturing industry on 
the Tobacco Products Scientific Advisory Committee. A nominee may 
either be

[[Page 54324]]

self-nominated or nominated by an organization to serve as a nonvoting 
industry representative. This position may be filled on a rotating, 
sequential basis by representatives of different small business tobacco 
manufacturers based on areas of expertise relevant to the topics being 
considered by the Advisory Committee. Nominations will be accepted for 
current vacancies effective with this notice.

DATES: Any small business tobacco manufacturing industry organization 
interested in participating in the selection of appropriate nonvoting 
members to represent industry interests must send a letter stating that 
interest to the FDA by September 11, 2023, (see sections I and II of 
this document for further details). Concurrently, nomination materials 
for prospective candidates should be sent to FDA by September 11, 2023.

ADDRESSES: All statements of interest from small business tobacco 
manufacturing industry organizations interested in participating in the 
selection process of nonvoting industry representative nominations 
should be sent to CAPT Serina Hunter-Thomas (see FOR FURTHER 
INFORMATION CONTACT). All nominations for nonvoting industry 
representatives may be submitted electronically by accessing the FDA 
Advisory Committee Membership Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm. 
Information about becoming a member of an FDA advisory committee can 
also be obtained by visiting FDA's website http://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Serina Hunter-Thomas, Office of 
Science, Center for Tobacco Products, Food and Drug Administration, 
Center for Tobacco Products Document Control Center, Bldg. 71, Rm. 
G335, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-
287-1373 (choose Option 5), or by email: [email protected].

SUPPLEMENTARY INFORMATION: The Agency intends to add nonvoting industry 
representative(s) to the following advisory committee:

I. Tobacco Products Scientific Advisory Committee

    The Tobacco Products Scientific Advisory Committee (the Committee) 
advises the Commissioner of FDA (the Commissioner) or designee in 
discharging responsibilities related to the regulation of tobacco 
products. The Committee reviews and evaluates safety, dependence, and 
health issues relating to tobacco products and provides appropriate 
advice, information, and recommendations to the Commissioner.
    The Committee includes three nonvoting members who represent 
industry interests. These members include one representative 
representing the interests of the tobacco manufacturing industry, one 
representative representing the interests of tobacco growers, and one 
representative representing the interests of the small business tobacco 
manufacturing industry, which may be filled on a rotating, sequential 
basis by representatives of different small business tobacco 
manufacturers based on areas of expertise relevant to the topics being 
considered by the Advisory Committee.
    With this notice, nominations are sought for the following 
positions: A pool of individuals, with varying areas of expertise, to 
represent the interests of the small business tobacco manufacturing 
industry on a rotating, sequential basis.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document (see DATES). Within the subsequent 30 days, FDA will send 
a letter to each organization that has expressed an interest, attaching 
a complete list of all such organizations and a list of all nominees 
along with their current resumes. The letter will also state that it is 
the responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days after the receipt of 
the FDA letter, to serve as the nonvoting member to represent industry 
interests for the committee. The interested organizations are not bound 
by the list of nominees in selecting a candidate. However, if no 
individual is selected within 60 days, the Commissioner will select the 
nonvoting member to represent industry interests.

III. Application Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting industry 
representative. Contact information, a current curriculum vitae, and 
the name of the committee of interest should be sent to the FDA 
Advisory Committee Membership Nomination Portal (see ADDRESSES) within 
30 days of publication of this document (see DATES). FDA will forward 
all nominations to the organizations expressing interest in 
participating in the selection process for the committee. (Persons who 
nominate themselves as nonvoting industry representatives will not 
participate in the selection process).
    FDA seeks to include the views of women, and men, members of all 
racial and ethnic groups and individuals with and without disabilities 
on its advisory committees and, therefore encourages nominations of 
appropriately qualified candidates from these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: August 7, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-17149 Filed 8-9-23; 8:45 am]
BILLING CODE 4164-01-P


